Evaluating the Effects of Tasimelteon vs. Placebo on Jet Lag Type Insomnia

• Status: Completed
• Trial end date: 2018-03-05
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this study is to investigate tasimelteon vs. placebo on sleep in healthy individuals after a phase advance in jet lag type insomnia.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Vanda Pharmaceuticals

Criteria

Inclusion Criteria:

• Ability and acceptance to provide written consent, fluent in English;

• Healthy subjects with no medical, psychiatric or current sleep disorders;

• Men or women between 18-75 years;

• Body Mass Index of ≥ 18 and ≤ 30 kg/m2.

Exclusion Criteria:

• Major surgery, trauma, illness or immobile for 3 or more days within the past month;

• Pregnancy or recent pregnancy (within 6 weeks);

• A positive test for drugs of abuse at the screening or evaluation visit.